000 | 01857 a2200481 4500 | ||
---|---|---|---|
005 | 20250510211733.0 | ||
264 | 0 | _c19781202 | |
008 | 197812s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm00206a026 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWitiak, D T | |
245 | 0 | 0 |
_aDiethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cAug 1978 |
||
300 |
_a833-7 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzofurans _xchemical synthesis |
650 | 0 | 4 |
_aCholesterol _xblood |
650 | 0 | 4 |
_aClofibrate _xpharmacology |
650 | 0 | 4 |
_aCyclobutanes _xchemical synthesis |
650 | 0 | 4 |
_aEthylmorphine-N-Demethylase _xmetabolism |
650 | 0 | 4 |
_aHydroxymethylglutaryl CoA Reductases _xmetabolism |
650 | 0 | 4 |
_aHyperlipidemias _xblood |
650 | 0 | 4 |
_aHypolipidemic Agents _xchemical synthesis |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
650 | 0 | 4 | _aMolecular Conformation |
650 | 0 | 4 |
_aNADPH-Ferrihemoprotein Reductase _xmetabolism |
650 | 0 | 4 |
_aOrgan Size _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSucrose _xpharmacology |
650 | 0 | 4 |
_aTriglycerides _xblood |
700 | 1 | _aNewman, H A | |
700 | 1 | _aPoochikian, G K | |
700 | 1 | _aFogt, S W | |
700 | 1 | _aBaldwin, J R | |
700 | 1 | _aSober, C L | |
700 | 1 | _aFeller, D R | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 21 _gno. 8 _gp. 833-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00206a026 _zAvailable from publisher's website |
999 |
_c97441 _d97441 |